{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:24Z","timestamp":1791232404449,"version":"4.1.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Background:<\/jats:italic>\n                    Patients with substance use disorders (SUDs) are more likely to experience serious health problems, high healthcare utilization, and premature death. However, little is known about the contribution of SUDs to medical 30-day readmission risk. We examined the association between SUDs and 30-day all cause readmission among non-pregnant adult in-patients in the US.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                    We conducted a retrospective study using 2010\u20132014 data from the Nationwide Readmissions Database. Our primary focus was on opioid use compared to stimulant use (cocaine and amphetamine) identified by ICD-9-CM diagnosis codes in index hospitalizations. Multivariable logistic regression models were used to estimate adjusted odds ratios and 95% CI representing the association between substance use and 30-day readmission, overall and stratified by the principal reason for the index hospitalization.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                    Nearly 118 million index hospitalizations were included in the study, 4% were associated with opioid or stimulant use disorder. Readmission rates for users (19.5%) were higher than for nonusers (15.7%), with slight variation by the type of substance used: cocaine (21.8%), opioid (19.0%), and amphetamine (17.5%). After adjusting for key demographic, socioeconomic, clinical, and health system characteristics, SUDs and stimulant use disorders increased the odds of 30-day all-cause readmission by 20%.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic>\n                    Reducing the frequency of inpatient readmission is an important goal for improving the quality of care and ensuring proper transition to residential\/outpatient care among patients with SUDs. Differences between groups may suggest directions for further investigation into the distinct needs and challenges of hospitalized opioid- and other drug-exposed patients.\n                  <\/jats:p>","DOI":"10.1080\/08897077.2019.1635964","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T15:11:26Z","timestamp":1562857886000},"page":"365-374","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":28,"title":["Opioid, Cocaine, and Amphetamine use Disorders are Associated with Higher30-Day Inpatient Readmission Rates in the United States"],"prefix":"10.1177","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-8688","authenticated-orcid":false,"given":"Maria C.","family":"Mejia de Grubb","sequence":"first","affiliation":[{"name":"Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0077-6023","authenticated-orcid":false,"given":"Jason L.","family":"Salemi","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Chima","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia A.","family":"Kowalchuk","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Zoorob","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"e_1_3_1_2_2","unstructured":"Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044 NSDUH Series H-52). Rockville MD: Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration. Retrieved from https:\/\/www.samhsa.gov\/data\/."},{"key":"e_1_3_1_3_2","unstructured":"Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927 NSDUH Series H-50). Retrieved from http:\/\/www.samhsa.gov\/data\/."},{"key":"e_1_3_1_4_2","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Weiss AJ","year":"2006","unstructured":"Weiss AJ, , Bailey MK, , O'Malley L, . Patient Characteristics of Opioid-Related Inpatient Stays and Emergency Department Visits Nationally and by State, 2014: Statistical Brief #224. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2953"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0143-4"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002136"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1251"},{"key":"e_1_3_1_10_2","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Fingar K","year":"2006","unstructured":"Fingar K, , Washington R. Trends in hospital readmissions for four High-Volume conditions, 2009-2013: Statistical Brief #196. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2014\/17\/E503"},{"key":"e_1_3_1_12_2","unstructured":"Department of Health. State of Rhode Island. Potentially Preventable Readmissions Related to Behavioral Health in Rhode Island (2013). http:\/\/www.health.ri.gov\/data\/pprbehavioral\/. Accessed 21 June 2018"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181ff04ca"},{"key":"e_1_3_1_14_2","unstructured":"Center for Substance Abuse Treatment. Substance Abuse: Clinical Issues in Intensive Outpatient Treatment. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2006. (Treatment Improvement Protocol (TIP) Series No. 47.) Chapter 3. Intensive Outpatient Treatment and the Continuum of Care. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64088\/."},{"key":"e_1_3_1_15_2","unstructured":"Healthcare Cost and Utilization Project (HCUP). Nationwide Readmission Database (NRD) overview. Available at: http:\/\/www.hcup-us.ahrq.gov\/nrdoverview.jsp. Accessed 10 May 2017."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.07.023"},{"key":"e_1_3_1_17_2","volume-title":"2013 NCHS Urban\u2013Rural classification scheme for counties","author":"Rothwell CJ","year":"2014","unstructured":"Rothwell CJ, , Madans JH, , Arispe IE. 2013 NCHS Urban\u2013Rural classification scheme for counties. Hyattsville, MD: Data Evaluation and Methods Research; 2014."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.5888\/pcd10.120239"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12613"},{"key":"e_1_3_1_20_2","unstructured":"Fingar KR (IBM Watson Health) Skinner H (IBM Watson Health) Johann J (IBM Watson Health) Coenen N (IBM Watson Health) Freeman WJ (AHRQ) Heslin KC (AHRQ). Geographic Variation in Substance-Related Inpatient Stays Across States and Counties in the United States 2013\u20132015. HCUP Statistical Brief #245. November 2018. Agency for Healthcare Research and Quality Rockville MD. www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb244-Opioid-Inpatient-Stays-ED-Visits-Older-Adults.pdf."},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.01.001"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pu.17.050196.001355"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1561"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1201268"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1515"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-017-4077-z"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.2736"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.4065\/84.3.255"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.022"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160290"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1101942"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17653"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1635964","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2019.1635964","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1635964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:08:32Z","timestamp":1780492112000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2019.1635964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1080\/08897077.2019.1635964"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2019.1635964","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}